Preferences help
enabled [disable] Abstract
Number of results
2008 | 55 | 3 | 613-617
Article title

Influence of phosphorohydrazone derivatives of benzopyrones on polymerization and viscosity of fibrin

Title variants
Languages of publication
The synthesis and antitumour and antibacterial activity of coumarin and chromone phosphorohydrazones have been reported. This study describes influence of phosphorohydrazones derivatives of coumarin and chromone on the polymerization and viscosity of fibrin. The fibrin polymerization assay was performed by the Shen and Lorand method and the clot viscosity was measured on the basis of Shen and Lorand and Marchi and coworkers methods. Among the eight compounds tested, one coumarin derivative and two chromone derivatives showed significant activity.
Physical description
  • Blombäck BD, Banerjee K, Carlsson K, Hamsten A, Hessel B, Procyk R, Silveira A, Zacharski L (1990) Native fibrin gel networks and factors influencing their formation in health and disease. In Fibrinogen, Thrombosis, Coagulation and Fibrinolysis. Liu CY, Chien S, eds, pp 1-23. Plenum Press, New York.
  • Bromberg ME, Capello M (1999) Cancer and blood coagulation: molecular aspects. Cancer J Sci Am 5: 132-138.
  • Di Braccio M, Grossi G, Roma G, Marzano C, Baccichetti F, Simonato M, Bordin F (2003) Part XXI. Antiproliferative and cytotoxic properties of novel N-substituted 4-aminocoumarins, their benzo-fused derivatives, and some related 2-aminochromones. Il Farmaco 58: 1083-1097.
  • Fernandez PM, Patierno SR, Rickles RR (2004) Tissue factor and fibrin in tumor angiogenesis. Semin Thromb Hemost 30: 31-34.
  • Gron BC, Filion-Myklobust S, Bennick W, Nieuwenhuizen GR, Matsueda A, Brosstad F (1992) Early cross-linked fibrin in human plasma contains α-polymers with intact fibrinopeptide. Blood Coagul Fibrinolysis 3: 731-736.
  • Hayen W, Goebeler M, Kumar S, Riessen R, Nehis V (1999) Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture. J Cell Sci 112: 2241-251.
  • Kawase M, Varu B, Shah A, Motohashi N, Tani S, Saito S, Debnath S, Mahapatra S, Dastidar SG, Chakrabarty AN (2001) Antimicrobial activity of new coumarin derivatives. Arzneim-Forsch Drug Res 51: 67-71.
  • Kostova I (2005) Synthetic and natural coumarins as cytotoxic agents. Curr Med Chem Anticancer Agents 5: 29-46.
  • Kostova I, Momekov G, Stancheva P (2007) New samarium(III), gadolinium(III) and dysprosium(III) complexes of coumarin-3-carboxylic acid as antiproliferative agents. Met Based Drugs 2007: 1-8.
  • Kośmider B, Wyszyńska K, Janik-Spiechowicz E, Osiecka R, Zyner E, Ochocki J, Ciesielska E, Wasowicz W (2004) Evaluation of the genotoxity of cis-bis(3-aminoflavone)dichloroplatinum(II) in comparison with cis-DDP. Mutat Res 558: 93- 110.
  • Libionka A, Figiel W, Maga P, Gackowski A, Rostoff P, Paradowski A, Piwowarska W, Niżanowski R, Szczeklik A (2005) Blood viscosity in cardiac syndrome X and other cardiovascular disorders. Folia Cardiol 12: 465-470.
  • Marchi R, Arocha-Piňango CL, Nagy H, Matsuda M, Weisel JW (2004) The effects of additional carbohydrate in the coiled-coil region of fibrinogen on polymerization and clot structure and properties: characterization of the homozygous and heterozygous forms of fibrinogen Lima (Aα Arg141-->Ser with extra glycosylation). J Thromb Haemost 2: 940-948.
  • Michalska M, Wierzbicki R (1990) Mercury (II) increases turbidity in the presence of fibrinopeptides. J Trace Elem Exp Med 3: 1-7.
  • Michalska M, Wierzbicki R (1993) Effect of methylmercuric chloride (MMC) on fibrin polymerization. Biol Trace Elem Res 37: 157-161.
  • Mills JD, Ariens RAS, Mansfield MW, Grant PJ (2002) Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation 106: 1938-1942.
  • Mosesson MW (1990) Fibrin polymerization and its regulatory role in hemostasis. J Lab Clin Med 116: 8-17.
  • Nawrot-Modranka J, Nawrot E (2007) Synthesis, spectroscopy and alkylating properties of Pd(II) complexes of phosphorohydrazones of coumarin with potential antibacterial activity. Acta Pol Pharm 64: 429-434.
  • Nawrot-Modranka J, Ochocki J, Graczyk J (2004) Phosphorohydrazines of 4-oxo-4H-1-benzopyran and 1-benzopyran-2, 4-dione exhibit antitumor activity against L 1210 leukemia. Pharmazie 59: 731-732.
  • Nawrot-Modranka J, Nawrot E, Graczyk J (2006) In vivo antitumor, in vitro antibacterial activity alkylation properties of phosphohydrazine derivatives of coumarin and chromone. Eur J Med Chem 41: 1301-1309.
  • Oenick MD (2004) Studies on fibrin polymerization and fibrin structure - a retrospective. Biophys Chem 112: 187-192.
  • Rettie AE, Tai G (2006) Pharmacogenomics of Warfarin metabolism. Mol Interv 6: 223-227.
  • Richard DE, Vouret-Craviari V, Pouyssegur J (2001) Angiogenesis and G-protein-coupled receptors: signals that bridge the gap. Oncogene 20: 1556-1562.
  • Ryan ER, Mockros LF, Weisel JW, Lorand L (1999) Structural origins of fibrin clot rheology. Biophys J 77: 2813-2826.
  • Rybarczyk-Pirek AJ, Olszak TA, Małecka M, Nawrot-Modranka J (1999) X-ray investigations of benzopyran derivatives substituted at position 3. Acta Crystallogr C 55: 1313-1315.
  • Rybarczyk-Pirek AJ, Grabowski SJ, Nawrot-Modranka J (2003) Bifurcated hydrogen bonds in crystal structures of new phosphorochromone derivatives. J Phys Chem A 107: 9232-9239.
  • Rybarczyk-Pirek AJ, Dubis AT, Grabowski SJ, Nawrot-Modranka J (2006) Intramolecular hydrogen bonds in crystals of thiophosphorylbenzopyrane derivatives - X-ray and FT-IR studies. Chem Phys 320: 247-258.
  • Shen L, Lorand L (1983) Contribution of fibrin stabilization to clot strength. J Clin Invest 71: 1336-1341.
  • Standeven KF, Arlëns RAS, Whitaker P, Ashcroft AE, Weisel JW, Grant PJ (2002) The effect of dimethylbiguanide on thrombin activity, F XIII activation, fibrin polymerization and fibrin clot formation. Diabetes 51: 189-197.
  • von Tempelhoff GF, Heilman L, Hommel G (1998) Hyperviscosity syndrome in patients with ovarian carcinoma. Cancer 82: 1104-1111.
  • von Tempelhoff GF, Nieman F, Heilmann L, Hommel G (2002) Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy. Clin Hemorheol Microcirc 22: 107-130.
  • Wojtukiewicz MZ, Sierko E, Klement P, Rak J (2001) The hemostatic system and angiogenesis in malignancy. Neoplasia 3: 371-384.
  • Wojtukiewicz MZ, Sierko E, Rak J (2004) Contribution of the hemostatic system to angiogenesis in cancer. Semin Thromb Hemost 30: 5-20.
  • Zyner E, Ochocki J (1999) Platinum(II) and palladium(II) N,O-chelates with substituted flavanone containing ligands. Acta Pol Pharm 56: 159-116.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.